The tetraspanin CD81 regulates the expression of CD19 during B cell development in a postendoplasmic reticulum compartment

Journal of Immunology

Volumn 171, Issue 8, 2003, Pages 4062-4072

  Shoham, Tsipi ^a   Rajapaksa, Ranjani ^a   Boucheix, Claude ^b   Rubinstein, Eric ^b   Poe, Jonathan C ^c   Tedder, Thomas F ^c   Levy, Shoshana ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HÔPITAL PAUL BROUSSE   (France)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD81 ANTIGEN; MESSENGER RNA; TETRASPANIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOPLASMIC RETICULUM; FEMALE; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0141923758     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.8.4062     Document Type: Article

References (44)

1. Maecker, H. T., M. S. Do, and S. Levy. 1998. CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responses. Proc. Natl. Acad. Sci. USA 95:2458.
2. Deng, J., V. P. Yeung, D. Tsitoura, R. H. DeKruyff, D. T. Umetsu, and S. Levy. 2000. Allergen-induced airway hyperreactivity is diminished in CD81-deficient mice. J. Immunol. 165:5054.
3. Kelic, S., S. Levy, C. Suarez, and D. E. Weinstein. 2001. CD81 regulates neuron-induced astrocyte cell-cycle exit. Mol. Cell Neurosci. 17:551.
4. Deng, J., R. H. Dekruyff, G. J. Freeman, D. T. Umetsu, and S. Levy. 2002. Critical role of CD81 in cognate T-B cell interactions leading to Th2 responses. Int. Immunol. 14:513.
5. Geisert, E. E. J., R. W. Williams, G. R. Geisert, L. Fan, A. M. Asbury, H. T. Maecker, J. Deng, and S. Levy. 2002. Increased brain size and glial cell number in CD81-null mice. J. Comp. Neurol. 453:22.
6. Le Naour, F., E. Rubinstein, C. Jasmin, M. Prenant, and C. Boucheix. 2000. Severely reduced female fertility in CD9-deficient mice. Science 287:319.
7. Silvie, O., E. Rubinstein, J. F. Franetich, M. Prenant, E. Belnoue, L. Renia, L. Hannoun, W. Eling, S. Levy, C. Boucheix, and D. Mazier. 2003. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat. Med. 9:93.
8. Pileri, P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. J. Weiner, M. Houghton, D. Rosa, G. Grandi, and S. Abrignani. 1998. Binding of hepatitis C virus to CD81. Science 282:938.
9. Levy, S., S. C. Todd, and H. T. Maecker. 1998. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16:89.
10. Rubinstein, E., F. Le Naour, C. Lagaudriere-Gesbert, M. Billard, H. Conjeaud, and C. Boucheix. 1996. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26:2657.
11. Maecker, H. T., S. C. Todd, and S. Levy. 1997. The tetraspanin superfamily: molecular facilitators. FASEB J. 11:428.
12. Bradbury, L. E., G. S. Kansas, S. Levy, R. L. Evans, and T. F. Tedder. 1992. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 149:2841.
13. Fearon, D. T., and R. H. Carter. 1995. The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127.
14. Sato, S., A. S. Miller, M. C. Howard, and T. F. Tedder. 1997. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 159:3278.
15. Maecker, H. T., and S. Levy. 1997a. Normal lymphocyte development but delayed humoral immune response in CD81-null mice. J. Exp. Med. 185:1505.
16. Miyazaki, T., U. Muller, and K. S. Campbell. 1997. Normal development but differentially altered proliferative responses of lymphocytes in mice lacking CD81. EMBO J. 16:4217.
17. Tsitsikov, E. N., J. C. Gutierrez-Ramos, and R. S. Geha. 1997. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81- deficient mice. Proc. Natl. Acad. Sci. USA 94:10844.
18. Kropshofer, H., S. Spindeldreher, T. A. Rohn, N. Platania, C. Grygar, N. Daniel, A. Wolpl, H. Langen, V. Horejsi, and A. B. Vogt. 2002. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 3:61.
19. Fritzsching, B., B. Schwer, J. Kartenbeck, A. Pedal, V. Horejsi, and M. Ott. 2002. Release and intercellular transfer of cell surface CD81 via microparticles. J. Immunol. 169:5531.
20. Engel, P., L. J. Zhou, D. C. Ord, S. Sato, B. Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 3:39.
21. Otero, D. C., S. A. Omori, and R. C. Rickert. 2001. CD19-dependent activation of Akt kinase in B-lymphocytes. J. Biol. Chem. 276:1474.
22. Whitlock, C. A., D. Robertson, and O. N. Witte. 1984. Murine B cell lymphopoiesis in long term culture. J. Immunol. Methods 67:353.
23. Hardy, R. R., Y. S. Li, D. Allman, M. Asano, M. Gui, and K. Hayakawa. 2000. B-cell commitment, development and selection. Immunol. Rev. 175:23.
24. Rolink, A., F. Melchers, and J. Andersson. 1996. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching. Immunity 5:319.
25. Krop, I., A. R. de Fougerolles, R. R. Hardy, M. Allison, M. S. Schlissel, and D. T. Fearon. 1996. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:238.
26. Horvath, G., V. Serru, D. Clay, M. Billard, C. Boucheix, and E. Rubinstein. 1998. CD19 is linked to the integrin-associated tetraspans CD9, CD81, and CD82. J. Biol. Chem. 273:30537.
27. Krop, I., A. L. Shaffer, D. T. Fearon, and M. S. Schlissel. 1996. The signaling activity of murine CD19 is regulated during cell development. J. Immunol. 157:48.
28. Zhou, L. J., H. M. Smith, T. J. Waldschmidt, R. Schwarting, J. Daley, and T. F. Tedder. 1994. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol. Cell Biol. 14:3884.
29. Wong-Madden, S. T., and D. Landry. 1995. Purification and characterization of novel glycosidases from the bacterial genus Xanthomonas. Glycobiology 5:19.
30. Helenius, A., and M. Aebi. 2001. Intracellular functions of N-linked glycans. Science 291:2364.
31. Boucheix, C., and E. Rubinstein. 2001. Tetraspanins. Cell. Mol. Life Sci. 58:1189.
32. Stipp, C. S., T. V. Kolesnikova, and M. E. Hemler. 2003. Functional domains in tetraspanin proteins. Trends Biochem. Sci. 28:106.
33. Tedder, T. F., M. Inaoki, and S. Sato. 1997. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107.
34. Fearon, D. T., and M. C. Carroll. 2000. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:393.
35. Cherukuri, A., P. C. Cheng, and S. K. Pierce. 2001. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167:163.
36. Sato, S., N. Ono, D. A. Steeber, D. S. Pisetsky, and T. F. Tedder. 1996. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:4371.
37. Gauld, S. B., J. M. Dal-Porto, and J. C. Cambier. 2002. B cell antigen receptor signaling: roles in cell development and disease. Science 296:1641.
38. Kovesdi, D., G. Koncz, R. Ivanyi-Nagy, Y. Caspi, M. Ishiai, T. Kurosaki, J. Gergely, J. Haimovich, and G. Sarmay. 2002. Developmental differences in B cell receptor-induced signal transduction. Cell Signal. 14:563.
39. Shivtiel, S., N. Leider, O. Sadeh, Z. Kraiem, and D. Melamed. 2002. Impaired light chain allelic exclusion and lack of positive selection in immature B cells expressing incompetent receptor deficient of CD19. J. Immunol. 168:5596.
40. Marchbank, K. J., L. Kulik, M. G. Gipson, B. P. Morgan, and V. M. Holers. 2002. Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia. J. Immunol. 169:3526.
41. Hasegawa, M., M. Fujimoto, J. C. Poe, D. A. Steeber, and T. F. Tedder. 2001. CD19 can regulate B lymphocyte signal transduction independent of complement activation. J. Immunol. 167:3190.
42. Seigneuret, M., A. Delaguillaumie, C. Lagaudriere-Gesbert, and H. Conjeaud. 2001. Structure of the tetraspanin main extracellular domain: a partially conserved fold with a structurally variable domain insertion. J. Biol. Chem. 276:40055.
43. Ellgaard, L., M. Molinari, and A. Helenius. 1999. Setting the standards: quality control in the secretory pathway. Science 286:1882.
44. Wickner, S., M. R. Maurizi, and S. Gottesman. 1999. Posttranslational quality control: folding, refolding, and degrading proteins. Science 286:1888.